Factors associated with knowledge, attitudes, and behaviors regarding antiviral medications for COVID-19 among US adults
Groups that are less likely to have been vaccinated, those living in isolation, and those not sure about whether they would take an antiviral or not may be at risk for not receiving treatment to prevent severe COVID-19 outcomes. However, trust in doctor recommendations may be enough to overcome individual patient concerns about COVID-19 antivirals. Targeted initiatives to educate those at risk for severe COVID-19 outcomes about the effectiveness of antivirals may be needed to further lower this population's risk of severe COVID-19.
Authors
- Emilia H. Koumans (ORCID: https://orcid.org/0000-0001-7184-2107)
- Eghosa Oyegun (ORCID: https://orcid.org/0000-0003-2373-2530)
- Melissa Briggs Hagen (ORCID: https://orcid.org/0000-0001-7359-9665)
- Eric M. Roberts (ORCID: https://orcid.org/0000-0002-8583-7437)
- Allison Fisher
- Muyiwa Ategbole
- Lindsay Gutekunst
- Cynthia Jorgensen
Institutions
- Emory University (US)
- University of America (US)
- National Center for Immunization and Respiratory Diseases (US)
- Alaska Department of Health and Social Services (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-11-11
- DOI
- https://doi.org/10.1371/journal.pone.0335182
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 1.40
Funders
- Centers for Disease Control and Prevention